Sep 2026
Psychiatric Safety of GLP‐1 and Dual GIP/GLP‐1 Receptor Agonists in Adolescents With Obesity
Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and dual GIP/GLP‐1 receptor agonists are increasingly used for adolescent obesity, but concerns persist regarding psychiatric adverse events, particularly suicidality.
Ting-Hui Liu, Yang-Li Shen, Tien-Hsiang Kuo et al.
· Diabetes, obesity and metabo... · 0 citations